The ESH Second Translational Research Conference on immune and cellular therapies: Focus on Advanced Gene-Engineered Immune Cells proposes a programme of leading-edge basic and clinical science, as well as opportunities for informal scientific interaction with a panel of global experts in the field.
It is open to an international audience of biologists and clinicians, including those still in-training. This translational research conference will bring together biologists and clinicians with an interest in immune and cellular therapies with a focus on advanced gene-engineered immune cells.
New data will be presented and spirited debates on how to best to apply these insights to the future of immune and cellular therapies are expected.
Please note that the that the deadline for abstracts is July 24th, 2022.